The result also showed that SOD activity increased as an antioxidant response to pro-oxidant increment (CML and IL-1α) in the partially controlled blood glucose subgroup of the CAo + CAt group. This evidence concerns the gene IL1A and chronic myelogenous leukemia, BCR-ABL1 positive.